Stephen Kimmel, MD, MSCE
|Office Location||717, Blockley Hall|
|CCEB Appointment||Senior Scholar, Epidemiology|
|Primary Faculty Appointment||Professor of Medicine, Cardiovascular Medicine Division, University of Pennsylvania Perelman SOM|
|DBE Appointment||Professor of Epidemiology|
Acting Director, Clinical Epidemiology Unit, Center for Clinical Epidemiology and Biostatistics
Acting Director, Division of Epidemiology, Department of Biostatistics and Epidemiology
Dr. Kimmel's research focuses on cardiac pharmacoepidemiology, with a particular interest in the effects and proper use of drugs and devices for patients with coronary artery disease. He is currently principal investigator on a number of grants evaluating cardiac medications, including a study examining the relationship between myocardial infarction and use of nonsteroidal anti-inflammatory drugs and a study examining the effects of genetic polymorphisms and patient adherence on anticoagulation control. He is also the principal investigator of a randomized trial designed to test economic and behavioral interventions to improve adherence with antihypertensive drugs. Dr. Kimmel has extensive experience performing studies examining complications from, and the proper use of, cardiovascular devices. He also is actively studying the influence of laboratory experience on outcomes.
Kimmel SE, Berlin JA, Reilly M, Jaskowiak J, Kishel L, Chittams J, Strom BL. Patients exposed to Rofecoxib and Celecoxib have different odds of nonfatal myocardial infarction. Ann Intern Med. 2005; 142: 157-164.
Ilkhanoff L, Lewis JD, Hennessy S, Berlin JA, Kimmel SE. Potential limitations of electronic database studies of prescription non-aspirin non-steroidal anti-inflammatory drugs (NANSAIDs) and risk of myocardial infarction (MI). Pharmacoepidemiology and Drug Safety 2005; 14: 513-522.
Kimmel SE, Berlin JA, Reilly M, Jaskowiak J, Kishel L, Chittams J, Strom BL. The Effects of Nonselective Non-aspirin Nonsteroidal Anti-inflammatory Medication on the Risk of Nonfatal Myocardial Infarction and Their Interaction with Aspirin. JACC 2004; 43: 985-990.
Sauer WH, Berlin JA, Kimmel SE. The Effect of Antidepressants and their Relative Affinity for the Serotonin Transporter on the Risk of Myocardial Infarction. Circulation 2003; 108:32-36.
Kimmel SE, Sauer WH, Brensinger C, Hirshfeld J, Haber HL, Localio AR. Relationship between Coronary Angioplasty Laboratory Volume and Outcomes after Hospital Discharge. Am Heart J. 2002; 143: 833-40.
Kimmel SE, Localio AR, Krone RJ, Laskey WK. The Effects of Contemporary Use of Coronary Stents on In-hospital Mortality. J Am Coll Cardiol. 2001; 37: 499-504.
Sauer WH, Berlin JA, KIMMEL SE. Selective Serotonin Reuptake Inhibitors and Myocardial Infarction. Circulation 2001; 104: 1894-1898.
Localio AR, Berlin JA, Ten Have TR, Kimmel SE. Adjustments for Center in Multicenter Studies: An Overview. Ann Intern Med 2001; 135: 112-123.
Kimmel SE, Berlin JA, Laskey WK. The Relationship Between Coronary Angioplasty Procedure Volume and Major Complications. JAMA 1995; 274: 1137-1142.